FJFrançois Juge

François Juge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


François Juge has a total of 98 co-authors. Here are the top co-authors by number of shared publications:

  • Jamal Tazi

    IGMM-CNRS, University of Montpellier, 1919 Route de Mende, 34193 Montpellier, France

    5 shared publications
  • Agnès Audibert

    Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Centre National de la Recherche Scientifique Unité Mixte de Recherche 7622, Laboratoire de Biologie du Développement, F-75005, Paris, France

    4 shared publications
  • Martine Simonelig

    Institute of Human Genetics, University of Montpellier, CNRS, Montpellier, France

    4 shared publications
  • Céline Fernando

    Institut de Génétique Moléculaire de Montpellier, Unité Mixte de Recherche 5535, Centre National de la Recherche Scientifique, 1919 route de Mende, 34293 Montpellier Cedex 5, France Université de Montpellier, 163 rue Auguste Broussonnet, 34090 Montpellier, France

    3 shared publications
  • Krzysztof Rogowski

    Institute of Human Genetics

    3 shared publications
  • Béatrice Benoit

    INSERM UMR-S 1193, UFR de Pharmacie, University Paris-Saclay, Orsay, France

    2 shared publications

Latest Publications

  • Open Access

    Real‐time FRET assay for monitoring detyrosination by TMCP1 and VASH2

    by Matthieu Simon, Julien Espeut, François Juge, Muriel Amblard, Krzysztof Rogowski, Lubomir Vezenkov

    Tubulin detyrosination is an important α‐tubulin specific posttranslational modification which has been implicated in various disorders including neurodegeneration and cancer. As such, the enzymes involved in the generation of this modification emerged as promising therapeutic targets. Previous studies have identified the members of the vasohibin family, VASH1 and VASH2, as the first class of enzymes involved in the generation of detyrosination. Recently, we have discovered Tubulin MetalloCarboxyPeptidase 1 (TMCP1) as the second class of enzymes catalyzing this modification. Here we describe the development of a highly sensitive FRET‐based enzymatic assay to study and monitor the activity of TMCP1 and VASH2. The originality of this assay lies in the use of 3‐nitrotyrosine as a quencher, which not only restores fluorescence upon cleavage but also closely mimics the natural tyrosine substrate, ensuring optimal enzyme recognition. The selected fluorogenic substrate, named FS2, exhibited strong quenching efficiency and a high signal‐to‐noise ratio, allowing for real‐time kinetic monitoring of TMCP1 and VASH2 activity. Enzyme kinetics, competition assays, and metal ion dependency studies confirmed the assay's specificity, robustness, and physiological relevance. This optimized assay provides a powerful and reliable tool for the future identification and characterization of inhibitors of α‐tubulin detyrosination.

  • Open Access

    A family of carboxypeptidases catalyzing α- and β-tubulin tail processing and deglutamylation

    by Simon Nicot, Ghislain Gillard, Hathaichanok Impheng, Ewa Joachimiak, Serge Urbach, Kazufumi Mochizuki, Dorota Wloga, François Juge, Krzysztof Rogowski

    Tubulin posttranslational modifications represent an important mechanism involved in the regulation of microtubule functions. The most widespread among them are detyrosination, α∆2-tubulin, and polyglutamylation. Here, we describe a family of tubulin-modifying enzymes composed of two closely related proteins, KIAA0895L and KIAA0895, which have tubulin metallocarboxypeptidase activity and thus were termed TMCP1 and TMCP2, respectively. We show that TMCP1 (also known as MATCAP) acts as α-tubulin detyrosinase that also catalyzes α∆2-tubulin. In contrast, TMCP2 preferentially modifies βI-tubulin by removing three amino acids from its C terminus, generating previously unknown βI∆3 modification. We show that βI∆3-tubulin is mostly found on centrioles and mitotic spindles and in cilia. Moreover, we demonstrate that TMCPs also remove posttranslational polyglutamylation and thus act as tubulin deglutamylases. Together, our study describes the identification and comprehensive biochemical analysis of a previously unknown type of tubulin-modifying enzymes involved in the processing of α- and β-tubulin C-terminal tails and deglutamylation.


  • Modulation of Yorkie activity by alternative splicing is required for developmental stability

    by Diwas Srivastava, Marion de Toledo, Laurent Manchon, Jamal Tazi, François Juge

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.


  • Open Access

    The Mi-2 nucleosome remodeler and the Rpd3 histone deacetylase are involved in piRNA-guided heterochromatin formation

    by Bruno Mugat, Simon Nicot, Carolina Varela-Chavez, Christophe Jourdan, Kaoru Sato, Eugenia Basyuk, François Juge, Mikiko C. Siomi, Alain Pélisson, Séverine Chambeyron

    In eukaryotes, trimethylation of lysine 9 on histone H3 (H3K9) is associated with transcriptional silencing of transposable elements (TEs). In drosophila ovaries, this heterochromatic repressive mark is thought to be deposited by SetDB1 on TE genomic loci after the initial recognition of nascent transcripts by PIWI-interacting RNAs (piRNAs) loaded on the Piwi protein. Here, we show that the nucleosome remodeler Mi-2, in complex with its partner MEP-1, forms a subunit that is transiently associated, in a MEP-1 C-terminus-dependent manner, with known Piwi interactors, including a recently reported SUMO ligase, Su(var)2-10. Together with the histone deacetylase Rpd3, this module is involved in the piRNA-dependent TE silencing, correlated with H3K9 deacetylation and trimethylation. Therefore, drosophila piRNA-mediated transcriptional silencing involves three epigenetic effectors, a remodeler, Mi-2, an eraser, Rpd3 and a writer, SetDB1, in addition to the Su(var)2-10 SUMO ligase.


  • Open Access

    The PIWI protein Aubergine recruits eIF3 to activate translation in the germ plasm

    by Anne Ramat, Maria-Rosa Garcia-Silva, Camille Jahan, Rima Naït-Saïdi, Jérémy Dufourt, Céline Garret, Aymeric Chartier, Julie Cremaschi, Vipul Patel, Mathilde Decourcelle, et al.

    Piwi-interacting RNAs (piRNAs) and PIWI proteins are essential in germ cells to repress transposons and regulate mRNAs. InDrosophila, piRNAs bound to the PIWI protein Aubergine (Aub) are transferred maternally to the embryo and regulate maternal mRNA stability through two opposite roles. They target mRNAs by incomplete base pairing, leading to their destabilization in the soma and stabilization in the germ plasm. Here, we report a function of Aub in translation. Aub is required for translational activation ofnanosmRNA, a key determinant of the germ plasm. Aub physically interacts with the poly(A)-binding protein (PABP) and the translation initiation factor eIF3. Polysome gradient profiling reveals the role of Aub at the initiation step of translation. In the germ plasm, PABP and eIF3d assemble in foci that surround Aub-containing germ granules, and Aub acts with eIF3d to promotenanostranslation. These results identify translational activation as a new mode of mRNA regulation by Aub, highlighting the versatility of PIWI proteins in mRNA regulation.


  • Open Access

    Modulation of Yorkie activity by alternative splicing is required for developmental stability

    by Diwas Srivastava, Marion de Toledo, Laurent Manchon, Jamal Tazi, François Juge

    The mechanisms that contribute to developmental stability are barely known. Here we show that alternative splicing ofyorkie(yki) is required for developmental stability inDrosophila. Yki encodes the effector of the Hippo pathway that has a central role in controlling organ growth and regeneration. We identify the splicing factor B52 as necessary for inclusion ofykialternative exon 3 that encodes one of the two WW domains of Yki protein. B52 depletion favors expression of Yki1 isoform carrying a single WW domain, and reduces growth in part through modulation ofykialternative splicing. Compared to the canonical Yki2 isoform containing two WW domains, Yki1 isoform has reduced transcriptional and growth-promoting activities, decreased binding to PPxY-containing partners, and lacks the ability to bridge two proteins containing PPxY motifs. Yet, Yki1 and Yki2 interact similarly with transcription factors and can thus competein vivo. Strikingly, flies deprived from Yki1 isoform exhibit increased fluctuating wing asymmetry, a signal of increased developmental noise. Our results identifyykialternative splicing as a new level of control of the Hippo pathway and provide the first experimental evidence that alternative splicing participates in developmental robustness.


  • Novel interactors of the Drosophila Survival Motor Neuron (SMN) Complex suggest its full conservation

    by Maia Lanfranco, Rebecca Cacciottolo, Rebecca M. Borg, Neville Vassallo, François Juge, Rémy Bordonné, Ruben J. Cauchi

    The Spinal Muscular Atrophy disease protein Survival Motor Neuron (SMN) operates as part of a multiprotein complex whose components also include Gemins 2‐8 and Unrip. The fruit fly Drosophila melanogaster is thought to have a slightly smaller SMN complex comprised of SMN, Gemin2/3/5 and, possibly, Unrip. Based upon in vivo interaction methods, we have identified novel interacting partners of the Drosophila SMN complex with homologies to Gemin4/6/7/8. The Gemin4 and Gemin8 orthologues are required for neuromuscular function and survival. The Gemin6/7/Unrip module can be recruited via the SMN‐associated Gemin8, hence mirroring the human SMN complex architecture. Our findings lead us to propose that an elaborate SMN complex that is typical in metazoans is also present in Drosophila.


  • Splicing factors act as genetic modulators of TDP-43 production in a new autoregulatory TDP-43 Drosophila model

    by Marine Pons, Laetitia Miguel, Camille Miel, Tracey Avequin, François Juge, Thierry Frebourg, Dominique Campion, Magalie Lecourtois

    TDP-43 is a critical RNA-binding factor associated with RNA metabolism. In the physiological state, maintaining normal TDP-43 protein levels is critical for proper physiological functions of the cells. As such, TDP-43 expression is tightly regulated through an autoregulatory negative feedback loop. TDP-43 is a major disease-causing protein in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration (FTLD). Several studies argue for a pathogenic role of elevated TDP-43 levels in these disorders. Modulating the cycle of TDP-43 production might therefore provide a new therapeutic strategy. In this study, we developed a new transgenic Drosophila model mimicking the TDP-43 autoregulatory feedback loop in order to identify genetic modulators of TDP-43 protein steady-state levels in vivo. First, we showed that our TDP-43_TDPBR Drosophila model recapitulates key features of the TDP-43 autoregulatory processes previously described in mammalian and cellular models, namely alternative splicing events, differential usage of polyadenylation sites, nuclear retention of the transcript and a decrease in steady-state mRNA levels. Using this new Drosophila model, we identified several splicing factors, including SF2, Rbp1 and Sf3b1, as genetic modulators of TDP-43 production. Interestingly, our data indicate that these three RNA-binding proteins regulate TDP-43 protein production, at least in part, by controlling mRNA steady-state levels.


  • Open Access

    A Role for the Serine/Arginine-Rich (SR) Protein B52/SRSF6 in Cell Growth and Myc Expression in Drosophila

    by Céline Fernando, Agnès Audibert, Françoise Simon, Jamal Tazi, François Juge

    Serine-/arginine-rich (SR) proteins are RNA-binding proteins that are primarily involved in alternative splicing. Expression of some SR proteins is frequently upregulated in tumors, and previous reports have demonstrated that these proteins can directly participate in cell transformation. Identifying factors that can rescue the effects of SR overexpression in vivo is, therefore, of potential therapeutic interest. Here, we analyzed phenotypes induced by overexpression of the SR protein B52 during Drosophila development and identified several proteins that can rescue these phenotypes. Using the mechanosensory bristle lineage as a developmental model, we show that B52 expression level influences cell growth, but not differentiation, in this lineage. In particular, B52 overexpression increases cell growth, upregulates myc transcription, and gives rise to flies lacking thoracic bristles. Using a genetic screen, we identified several suppressors of the phenotypes induced by overexpression of B52 in vivo in two different organs. We show that upregulation of brain tumor (brat), a tumor suppressor and post-transcriptional repressor of myc, and downregulation of lilliputian (lilli), a subunit of the superelongation complex involved in transcription elongation, efficiently rescue the phenotypes induced by B52 overexpression. Our results demonstrate a role of this SR protein in cell growth and identify candidate proteins that may overcome the effects of SR protein overexpression in mammals.


  • Multifunctional RNA Processing Protein SRm160 Induces Apoptosis and Regulates Eye and Genital Development in Drosophila

    by Yu-Jie Fan, Aryn H Gittis, François Juge, Chen Qiu, Yong-Zhen Xu, Leonard Rabinow

    SRm160 is an SR-like protein implicated in multiple steps of RNA processing and nucleocytoplasmic export. Although its biochemical functions have been extensively described, its genetic interactions and potential participation in signaling pathways remain largely unknown, despite the fact that it is highly phosphorylated in both mammalian cells and Drosophila. To begin elucidating the functions of the protein in signaling and its potential role in developmental processes, we characterized mutant and overexpression SRm160 phenotypes in Drosophila and their interactions with the locus encoding the LAMMER protein kinase, Doa. SRm160 mutations are recessive lethal, while its overexpression generates phenotypes including roughened eyes and highly disorganized internal eye structure, which are due at least in part to aberrantly high levels of apoptosis. SRm160 is required for normal somatic sex determination, since its alleles strongly enhance a subtle sex transformation phenotype induced by Doa kinase alleles. Moreover, modification of SRm160 by DOA kinase appears to be necessary for its activity, since Doa alleles suppress phenotypes induced by SRm160 overexpression in the eye and enhance those in genital discs. Modification of SRm160 may occur through direct interaction because DOA kinase phosphorylates it in vitro. Remarkably, SRm160 protein was concentrated in the nuclei of precellular embryos but was very rapidly excluded from nuclei or degraded coincident with cellularization. Also of interest, transcripts are restricted almost exclusively to the developing nervous system in mature embryos.